Cargando…

Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study

Background and Aims. To evaluate the effect of adding acarbose on glycemic excursions measured by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes mellitus (T2DM) already on insulin therapy. Materials and Methods. This was an opened and unblended study. 134 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng-fei, Xu, Xiao-hua, Fu, Li-yuan, Su, Xiao-fei, Wu, Jin-dan, Lu, Chun-feng, Ye, Lei, Ma, Jian-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658413/ https://www.ncbi.nlm.nih.gov/pubmed/26640487 http://dx.doi.org/10.1155/2015/903524

Ejemplares similares

Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections
por: Li, Feng-fei, et al.
Publicado: (2016)

Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance
por: Yun, Peng, et al.
Publicado: (2016)

The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2019)

Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
por: Li, Feng-fei, et al.
Publicado: (2016)

Method for evaluating the human bioequivalence of acarbose based on pharmacodynamic parameters
por: Xu, Su-Mei, et al.
Publicado: (2020)

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Bing-li, et al.
Publicado: (2018)

Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes
por: Huang, Jinxin, et al.
Publicado: (2023)

Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes
por: Liu, Bing-li, et al.
Publicado: (2020)

Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?
por: Wu, Baiyun, et al.
Publicado: (2022)

Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Li, Feng-fei, et al.
Publicado: (2016)

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes
por: Kim, Ji-Hyun, et al.
Publicado: (2015)

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
por: Huang, Jie, et al.
Publicado: (2020)

Acarbose is again on the stage
por: Altay, Mustafa
Publicado: (2022)

The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage
por: Wang, Jie, et al.
Publicado: (2018)

Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study
por: Song, Lu-Lu, et al.
Publicado: (2020)

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
por: Wettergreen, Sara A., et al.
Publicado: (2016)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
por: Li, Feng-fei, et al.
Publicado: (2017)

Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
por: He, Ke, et al.
Publicado: (2014)

Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2013)

A Case of Postprandial Hypotension in the Intensive Care Unit Treated With Acarbose
por: Choi, Joon Hyouk, et al.
Publicado: (2011)

Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
por: Li, Feng-fei, et al.
Publicado: (2016)

Correction: Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2014)

Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis
por: Wang, Biqing, et al.
Publicado: (2021)

Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study
por: Deng, Chui-Wen, et al.
Publicado: (2017)

On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)

Characterizing the effect of temperature fluctuation on the incidence of malaria: an epidemiological study in south-west China using the varying coefficient distributed lag non-linear model
por: Zhao, Xing, et al.
Publicado: (2014)

Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
por: Li, Feng-fei, et al.
Publicado: (2017)

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: Jin, Hongmei, et al.
Publicado: (2022)

Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulin
por: Klimontov, Vadim V., et al.
Publicado: (2016)

Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
por: Holmbäck, Ulf, et al.
Publicado: (2020)

Ingestion of Leucine + Phenylalanine with Glucose Produces an Additive Effect on Serum Insulin but Less than Additive Effect on Plasma Glucose
por: Iverson, Jennifer F., et al.
Publicado: (2013)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Wang, Na, et al.
Publicado: (2018)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

Enhanced acarbose production by Streptomyces M37 using a two-stage fermentation strategy
por: Ren, Fei, et al.
Publicado: (2017)

Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study
por: Jiang, Lan-lan, et al.
Publicado: (2021)

Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals
por: Major-Pedersen, A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3tjregm2brt5arclcsg78l8eub